Cough, asthma, and cysteinyl-leukotrienes

Pulmonary Pharmacology and Therapeutics

Volumn 26, Issue 5, 2013, Pages 514-519

  Niimi, Akio ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Asthma; Cough; Leukotriene receptor antagonists; Mast cells; Neutrophils; Substance P

Indexed keywords

ANTITUSSIVE AGENT; CAPSAICIN; CORTICOSTEROID; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL GRANULE PROTEIN; HISTAMINE; INTERLEUKIN 8; LEUKOCYTE ELASTASE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MAJOR BASIC PROTEIN; MONTELUKAST; PLACEBO; PROSTAGLANDIN D2; PROSTAGLANDIN E2; SUPEROXIDE; ZAFIRLUKAST;

AIRWAY REMODELING; ALLERGIC ASTHMA; ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; ATHEROSCLEROSIS; ATOPIC DERMATITIS; BRONCHODILATING ACTIVITY; BRONCHOSPASM; BRONCHUS BIOPSY; CHEMOTAXIS; CHRONIC COUGH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC URTICARIA; COUGH VARIANT ASTHMA; COUGHING; CYSTIC FIBROSIS; EOSINOPHIL; FUNGAL SINUSITIS; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INTERSTITIAL CYSTITIS; IRRITABLE COLON; LIVER ISCHEMIA; LUNG FIBROSIS; MAST CELL; MONOCYTE; MONOTHERAPY; NEUTROPHIL; NOSE POLYP; OTITIS MEDIA; PANCREATITIS; PARANASAL SINUS DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; SEPSIS; SPIROMETRY; SPUTUM LEVEL; SYSTEMIC MASTOCYTOSIS; VAGINA CANDIDIASIS; VIRAL BRONCHIOLITIS;

ASTHMA; COUGH; LEUKOTRIENE RECEPTOR ANTAGONISTS; MAST CELLS; NEUTROPHILS; SUBSTANCE P;

ACETATES; ANIMALS; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ANTITUSSIVE AGENTS; ASTHMA; COUGH; CYSTEINE; GLUCOCORTICOIDS; HUMANS; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENES; QUINOLINES; SPUTUM;

EID: 84882596391     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2013.06.003     Document Type: Article

References (48)

1. Niimi A., Chung K.F. Airway inflammation and remodelling changes in patients with chronic cough: do they tell us about the cause of cough?. Pulm Pharmacol Ther 2004, 17:441-446.
2. Chung K.F., Barnes P.J. Mediator antagonists. Asthma and COPD 2009, 655-662. Academic Press. 2nd ed.
3. Singh R.K., Gupta S., Dastidar S., Ray A. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics. Pharmacology 2010, 85:336-349.
4. Pavord I.D., Ward R., Woltmann G., Wardlaw A.J., Sheller J.R., Dworski R. Induced sputum eicosanoid concentrations in asthma. Am J Respir Crit Care Med 1999, 160:1905-1909.
5. Hallstrand Teal S., Henderson William R. An update on the role of leukotrienes in asthma. Curr Opin Allergy Clin Immunol 2010, 10:60-66.
6. Laviolette M., Malmstrom K., Lu S., Chervinsky P., Pujet J.C., Peszek I., et al. Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/beclomethasone additivity group. Am J Respir Crit Care Med 1999, 160:1862-1868.
7. 4-related albuterol usage and response to montelukast. JAllergy Clin Immunol 2008, 121:1365-1371.
8. Lazarus S.C., Chinchilli V.M., Rollings N.J., Boushey H.A., Cherniack R., Craig T.J., et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med 2007, 175:783-790.
9. Chalmers G.W., Macleod K.J., Little S.A., Thomson L.J., McSharry C.P., Thomson N.C. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 2002, 57:226-230.
10. Niimi A., Matsumoto H., Mishima M. Eosinophilic airway disorders associated with chronic cough. Pulm Pharmacol Ther 2009, 22:114-120.
11. Takemura M., Niimi A., Matsumoto H., Ueda T., Yamaguchi M., Matsuoka H., et al. Atopic features of cough variant asthma and classic asthma with wheezing. Clin Exp Allergy 2007, 37:1833-1839.
12. Matsumoto H., Niimi A., Takemura M., Ueda T., Yamaguchi M., Matsuoka H., et al. Features of cough variant asthma and classic asthma during methacholine-induced brochoconstriction: a cross- sectional study. Cough 2009 Mar 9, 5:3.
13. Niimi A., Amitani R., Suzuki K., Tanaka E., Murayama T., Kuze F. Eosinophilic inflammation in cough variant asthma. Eur Respir J 1998, 11:1064-1069.
14. Niimi A., Matsumoto H., Minakuchi M., Kitaichi M., Amitani R., et al. Airway remodelling in cough-variant asthma. Lancet 2000, 356:564-565.
15. Niimi A., Torrego A., Nicholson A.G., Cosio B.G., Oates T.B., Chung K.F. Nature of airway inflammation and remodeling in chronic cough. JAllergy Clin Immunol 2005, 116:565-570.
16. Matsumoto H., Niimi A., Tabuena R.P., Takemura M., Ueda T., Yamaguchi M., et al. Airway wall thickening in patients with cough variant asthma and nonasthmatic chronic cough. Chest 2007, 131:1042-1049.
17. Matsumoto H., Niimi A., Takemura M., Ueda T., Tabuena R., Yamaguchi M., et al. Prognosis of cough variant asthma: a retrospective analysis. JAsthma 2006, 43:131-135.
18. Dicpinigaitis P.V., Dobkin J.B., Reichel J. Antitussive effect of the leukotriene receptor antagonist zafirlukast in subjects with cough-variant asthma. JAsthma 2002, 39:291-297.
19. Spector S.L., Tan R.A. Effectiveness of montelukast in the treatment of cough variant asthma. Ann Allergy Asthma Immunol 2004, 93:232-236.
20. Kawai S., Baba K., Matsubara A., Shiono H., Okada T., Yamaguchi E. The efficacy of montelukast and airway mast cell profiles in patients with cough variant asthma. JAsthma 2008, 45:243-250.
21. Kita T., Fujimura M., Ogawa H., Nakatsumi Y., Nomura S., Ishiura Y., et al. Antitussive effects of the leukotriene receptor antagonist montelukast in patients with cough variant asthma and atopic cough. Allergol Int 2010, 59:185-192.
22. Takemura M., Niimi A., Matsumoto H., Ueda T., Matsuoka H., Yamaguchi M., et al. Clinical, physiological and anti-inflammatory effect of montelukast in patients with cough variant asthma. Respiration 2012, 83:308-315.
23. Birring S.S., Parker D., Brightling C.E., Bradding P., Wardlaw A.J., Pavord I.D. Induced sputum inflammatory mediator concentrations in chronic cough. Am J Respir Crit Care Med 2004, 169:15-19.
24. Biernacki W.A., Kharitonov S.A., Biernacka H.M., Barnes P.J. Effect of montelukast on exhaled leukotrienes and quality of life in asthmatic patients. Chest 2005, 128:1958-1963.
25. Yamaguchi M., Niimi A., Ueda T., Takemura M., Matsuoka H., Jinnai M., et al. Effect of inhaled corticosteroids on small airways in asthma: investigation using impulse oscillometry. Pulm Pharmacol Ther 2009, 22:326-332.
26. Kohno S., Okada K., Kadota J., Shioya T., Tanaka H., Tokuyama K., et al. The Japanese Respiratory Society guidelines for management of cough. Medical review (Tokyo) 2012, [in Japanese; English version will be published].
27. Fujimura M., Hara J., Myou S. Change in bronchial responsiveness and cough reflex sensitivity in patients with cough variant asthma: effect of inhaled corticosteroids. Cough 2005, 1:5.
28. Lee S.Y., Kim M.K., Shin C., Shim J.J., Kim H.K., Kang K.H., et al. Substance P-immmunoreactive nerves in endobronchial biopsies in cough-variant asthma and classsic asthma. Respiration 2003, 70:49-53.
29. Bloomquist E.I., Kream R.M. Leukotriene D4 acts in part to contract guinea pig ileum smooth muscle by releasing substance P. JPharmacol Exp Ther 1987, 240:523-528.
30. McAlexander M.A., Myers A.C., Undem B.J. Inhibition of 5-lipoxygenase diminishes neurally evoked tachykinergic contraction of guinea pig isolated airway. JPharmacol Exp Ther 1998, 285:602-607.
31. Pizzichini M.M., Pizzichini E., Parameswaran K., Clelland L., Efthimiadis A., Dolovich J., et al. Nonasthmatic chronic cough: no effect of treatment with an inhaled corticosteroid in patients without sputum eosinophilia. Can Respir J 1999, 6:323-330.
32. Yoshihara S., Kanno N., Ando T., Fukuda N., Abe T., Ichimura T., et al. Involvement of substance P in the paroxysmal cough of pertussis. Regul Pept 1993, 46:238-240.
33. Otsuka K., Niimi A., Matsumoto H., Ito I., Yamaguchi M., Matsuoka H., et al. Plasma substance P levels in patients with persistent cough. Respiration 2011, 82:431-438.
34. Kopriva F., Sobolová L., Szotkowská J., Zápalka M. Treatment of chronic cough in children with montelukast, a leukotriene receptor antagonist. JAsthma 2004, 41:715-720.
35. Kita T., Fujimura M., Ogawa H., Nakatsumi Y., Nomura S., Ishiura Y., et al. Antitussive effects of the leukotriene receptor antagonist montelukast in patients with cough variant asthma and atopic cough. Allergol Int 2010, 59:185-192.
36. Chang A.B., Winter D., Acworth J.P. Leukotriene receptor antagonist for prolonged non-specific cough in children. Cochrane Database Syst Rev 2006 Apr 19, 2:CD005602.
37. Jatakanon A., Lalloo U.G., Lim S., Chung K.F., Barnes P.J. Increased neutrophils and cytokines, TNF-alpha and IL-8, in induced sputum of non-asthmatic patients with chronic dry cough. Thorax 1999, 54:234-237.
38. Fitch P.S., Brown V., Schock B.C., Taylor R., Ennis M., Shields M.D. Chronic cough in children: bronchoalveolar lavage findings. Eur Respir J 2000, 16:1109-1114.
39. Hartl D., Griese M., Nicolai T., Zissel G., Prell C., Konstantopoulos N., et al. Pulmonary chemokines and their receptors differentiate children with asthma and chronic cough. JAllergy Clin Immunol 2005, 115:728-736.
40. Hara J., Fujimura M., Ueda A., Myou S., Oribe Y., Ohkura N., et al. Effect of pressure stress applied to the airway on cough-reflex sensitivity in guinea pigs. Am J Respir Crit Care Med 2008, 177:585-592.
41. Matsuoka H., Niimi A., Matsumoto H., Takemura M., Ueda T., Yamaguchi M., et al. Inflammatory subtypes in cough variant asthma: association with maintenance doses of inhaled corticosteroids. Chest 2010, 138:1418-1425.
42. Simpson J.L., Scott R., Boyle M.J., Gibson P.G. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 2006, 11:54-61.
43. Page S.M., Gleich G.J., Roebuck K.A., Thomas L.L., et al. Stimulation of neutrophil interleukin-8 production by eosinophil granule major basic protein. Am J Respir Cell Mol Biol 1999, 21:230-237.
44. Shenoy N.G., Gleich G.J., Thomas L.L. Eosinophil major basic protein stimulates neutrophil superoxide production by a class IA phosphoinositide 3-kinase andprotein kinase C-zeta-dependent pathway. JImmunol 2003, 171:3734-3741.
45. Tintinger G.R., Feldman C., Theron A.J., Anderson R. Montelukast: more than a cysteinyl leukotriene receptor antagonist?. ScientificWorldJournal 2010 Dec 14, 10:2403-2413.
46. Celik P., Sakar A., Havlucu Y., Yuksel H., Turkdogan P., Yorgancioglu A. Short-term effects of montelukast in stable patients with moderate to severe COPD. Respir Med 2005, 99:444-450.
47. 2012 IMS health intercontinental marketing service.
48. Niimi A. Geography and cough aetiology. Pulm Pharmacol Ther 2007, 20:383-387.